Patysheva Marina R, Fedorenko Anastasya A, Khozyainova Anna A, Denisov Evgeny V, Gerashchenko Tatiana S
Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Kooperativny Str. 5, Tomsk 634009, Russia.
Research Institute of Molecular and Cellular Medicine, Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya Str. 6, Moscow 115093, Russia.
Cancers (Basel). 2025 May 12;17(10):1638. doi: 10.3390/cancers17101638.
Metastasis is the leading cause of cancer-related deaths. During the metastatic cascade, cancer cells tightly interact with immune cells influencing each other in the tumor microenvironment and systemically. Monocytes are important components of immune evasion and critical regulators of cancer progression. They circulate through the bloodstream and contribute to the formation of a pro-tumor microenvironment both in the tumor and pre-metastatic niche. Whereas monocyte participation in cancer development and response to therapy has been described extensively, its impact on metastasis remains a completely uncovered area. This review first summarizes data concerning the influence of monocytes on metastasis formation during their presence in the circulation, primary tumor, and pre-metastatic niche. We also highlight the latest examinations into the clinical relevance of targeting monocytes to prevent metastasis.
转移是癌症相关死亡的主要原因。在转移级联过程中,癌细胞与免疫细胞紧密相互作用,在肿瘤微环境及全身范围内相互影响。单核细胞是免疫逃逸的重要组成部分,也是癌症进展的关键调节因子。它们在血液中循环,并在肿瘤和转移前生态位中促成促肿瘤微环境的形成。尽管单核细胞参与癌症发展及对治疗反应已被广泛描述,但其对转移的影响仍是一个完全未被揭示的领域。本综述首先总结了有关单核细胞在血液循环、原发性肿瘤和转移前生态位中存在期间对转移形成影响的数据。我们还重点介绍了针对单核细胞以预防转移的临床相关性的最新研究。